Search results
Tryptamine Therapeutics doses first subject in IV-infused psilocin trial
Clinical Trials Arena· 6 days agoA lead programme of Tryp, TRP-8803 is set to address several limitations of oral psilocybin therapy....
As concretisation threatens butterfly habitats, an expert shares tips on setting up gardens for the...
Indian Express· 2 hours agoMonsoon is a time when butterflies migrate from the rain-soaked Western Ghats to drier regions, so...
Explained: Sebi order on MII charges; Impact on stock brokers, investors
Business Standard India· 4 days agoIn its bid to create parity among market participants, with regards to turnover charges, the...
Bansal Wire IPO Day 1: Check subscription status, GMP and other details. Should you apply or not? |...
Livemint· 5 days agoBansal Wire IPO Day 1: Witnessing strong buying interest from retail as well as non-institutional...
ONDC to cut its discount funding by up to 75%; tells players not to adjust GST for discounts
CNBC Awaaz· 2 days agoThe Open Network for Digital Commerce (ONDC) plans a phased reduction of up to 75 percent in...
Broking stocks fall up to 11% after Sebi directs MIIs to levy uniform fees
Business Standard India· 6 days agoBroking company stocks including Angel One, IIFL Securities, 5Paisa Capital, SMC Global, Motilal...
Jay Bharat Maruti Ltd Director Discussions | India Infoline
India Infoline· 1 day agoYour Directors are pleased to present the 36th Annual Report on business and operations of your Company together with the Audited Financial Statement for the Financial Year ...
Russian-Indian relations: Moving forward despite pressure
Financial Express· 10 hours agoBilateral trade growth has increased sharply in 2023, reaching an unprecedented level of $65 billion
HIV breakthrough: Drug trial shows injection twice a year is 100% effective against infection - The...
The Economic Times· 14 hours agoA large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new...
J&J looks to challenge argenx’s Vyvgart with positive Phase III data
Clinical Trials Arena· 6 days agoGlobalData is the parent company of Clinical Trials Arena. Positive Phase III results The...